NCT07344714

Brief Summary

The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (\>6 hours of life).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Mar 2026Dec 2026

First Submitted

Initial submission to the registry

January 7, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 11, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

January 7, 2026

Last Update Submit

March 16, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Performance of the algorithmic prediction of the need for prolonged respiratory support, defined as >6 hours of life.

    Calculated sensitivity, specificity, positive- and negative-predictive values of the predicted outcomes compared to actual patient outcomes.

    1 years

  • Accuracy of algorithmic prediction of negative cases of Respiratory Distress Syndrome

    Total proportion of true negatives as determined by the digital point-of-care device algorithm predicting no diagnosis of Respiratory Distress Syndrome and the clinician does not diagnosis Respiratory Distress Syndrome. Reported as a calculation of # true negatives / (# true negatives + # false negatives).

    2 years

Eligibility Criteria

Age32 Weeks - 41 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates whose deliveries are attended by the Mayo Clinic neonatal resuscitation team.

You may qualify if:

  • Both of the following:
  • Neonates born at 32 completed weeks gestational age or older whose deliveries are attended by the neonatal resuscitation team and for whom routine gastric suctioning is indicated
  • Neonates whose parents actively accepted or did not actively decline the Minnesota Research Authorization.

You may not qualify if:

  • Any one of the following:
  • Neonates with known or suspected congenital anomalies
  • Neonates for whom only comfort measures are planned or possible at time of delivery
  • Neonates whose parents actively declined the Minnesota Research Authorization.
  • Neonates with other identifiable causes of respiratory distress including pneumothorax, meconium aspiration syndrome, or pneumonia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Related Publications (1)

  • Leigh BC, Liedl LM, Amsbaugh AL, Carey WA. Spectral analysis of gastric aspirates obtained shortly after birth predicts the need for prolonged respiratory support in neonates in a development cohort. Front Pediatr. 2025 Dec 11;13:1686794. doi: 10.3389/fped.2025.1686794. eCollection 2025.

Related Links

MeSH Terms

Conditions

Respiratory Distress Syndrome, NewbornTransient Tachypnea of the NewbornMeconium Aspiration SyndromeHyaline Membrane DiseasePneumothorax

Condition Hierarchy (Ancestors)

Respiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesTachypneaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung InjuryFetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPleural Diseases

Study Officials

  • William A. Carey, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lavonne M. Liedl, LRT

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 7, 2026

First Posted

January 15, 2026

Study Start

March 11, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations